Skip to main content
Springer logoLink to Springer
. 2021 Jun 23;23(7):48. doi: 10.1007/s11926-021-01034-6

Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update

Doruk Erkan 1,, Savino Sciascia 2, Maria Laura Bertolaccini 3, Hannah Cohen 4; APS ACTION Executive Committee
PMCID: PMC8329831  PMID: 34160696

Correction to: Current Rheumatology Reports

10.1007/s11926-021-01008-8

The original version of this article unfortunately contained mistakes. The group name, APS ACTION Executive Committee, should appear in the author group as shown above. In addition, its members that are listed below should be captured as individual authors within the group. Also, provided individual affiliations have to be added as well in the list of affiliations as shown below.

  • Danieli Andrade (University of Sao Paulo, Sao Paulo, Brazil)

  • Tatsuya Atsumi (University of Hokkaido, Sapporo, Japan)

  • Maria Gerosa (University of Milan, Milan, Italy)

  • Michelle Petri (Johns Hopkins University School of Medicine, Baltimore, MD, USA)

  • Robert Roubey (University of North Carolina, Chapel Hill, NC, USA)

  • Maria Tektonidou (National and Kapdistrian University of Athens, Athens, Greece)

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1007/s11926-021-01008-8

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Doruk Erkan, Email: erkand@hss.edu.

APS ACTION Executive Committee:

Danieli Andrade, Tatsuya Atsumi, Maria Gerosa, Michelle Petri, Robert Roubey, and Maria Tektonidou


Articles from Current Rheumatology Reports are provided here courtesy of Springer

RESOURCES